You are here: Industry Insights > Alembic

News List

Aleor Dermaceuticals receives USFDA nod for Desonide lotion expresspharma
August 27, 2020
It indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Alembic Pharmaceuticals receives US FDA’s tentative approval for Empagliflozin and Metformin Hydrochloride Tablets expresspharma
July 21, 2020
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Synjardy Tablets of Boehringer lngelheim Pharmaceuticals.
Indian pharma firms recall medications from US market expresspharma
July 06, 2020
Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders.
Alembic reports a 37 per cent hike in net profits expresspharma
July 31, 2019
Alembic Pharmaceuticals announced its consolidated financial results for the quarter ending June 30, 2019. The company’s net profit rose by 37 per cent in Q1FY20, amounting to Rs 124 cr from Rs 90 cr in the same period previous fiscal.
Alembic’s Ophthalmic Solution gets USFDA approval biospectrumasia
April 23, 2019
Alembic Pharmaceuticals Limited recently announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bimatoprost Ophthalmic Solution, 0.03%.
Alembic Pharma gets US FDA approval for insomnia treatment drug expressbpd
November 28, 2018
The approved abbreviated new drug application (ANDA) is the therapeutic equivalent to the reference listed drug product (RLD) Restoril Capsules
Alembic Pharma gets US FDA nod for diabetes drug financialexpress
September 18, 2018
The company’s product is a generic version of Takeda Pharma USA’s Kazano tablets
Alembic Pharma Q2 net rises to Rs 121 crore expressbpd
November 09, 2017
Alembic Pharmaceuticals reported a 1.44 per cent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended September 30, mainly on account of decline in total income.
Alembic Pharmaceuticals acquires Orit Laboratories expressbpd
November 02, 2017
The acquisition increases Alembic’s breadth and capabilities in the US with a competent R&D team
Alembic’s Doxycycline capsules receives US FDA approval expressbpd
August 01, 2017
The capsules are used in the treatment and prevention of infections caused by bacteria.

Previous page 1 2 3 4 Next page